Discover how isoindoline-1,3-dione derivatives show promise as acetylcholinesterase inhibitors in Alzheimer's disease treatment through computational and experimental studies.
Groundbreaking research on Apelin-13 and its potential role in treating Alzheimer's disease by suppressing neuroinflammation and activating the BDNF-TrkB pathway.
Discover how ganglioside GM1 regulates γ-secretase cleavage of APP, revealing a potential therapeutic target for Alzheimer's disease without the side effects of previous approaches.